Biologics for Autoimmune Conditions

← Back to Class List

PDL Status Values

Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the Non-Preferred Drugs in Select PDL Classes prior authorization criteria. New drugs will be listed as N until reviewed by the P&T Committee and are subject to the New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required but eligible patients will encounter a co-pay at the pharmacy.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.

To request a Prior Authorization, please use this form.

Generic Name Brand Name Form PDL
Status
Current Drug Use Criteria New Drug Evaluation
adalimumab HUMIRA PEN PEN IJ KIT Y PA Document  
adalimumab HUMIRA PEN CROHN-UC-HS STARTER PEN IJ KIT Y PA Document  
adalimumab HUMIRA PEN PSORIASIS-UVEITIS PEN IJ KIT Y PA Document  
adalimumab HUMIRA SYRINGEKIT Y PA Document  
adalimumab HUMIRA PEDIATRIC CROHN'S SYRINGEKIT Y PA Document  
etanercept ENBREL MINI CARTRIDGE Y PA Document  
etanercept ENBREL SURECLICK PEN INJCTR Y PA Document  
etanercept ENBREL SYRINGE Y PA Document  
etanercept ENBREL VIAL Y PA Document  
abatacept ORENCIA CLICKJECT AUTO INJCT N PA Document  
abatacept ORENCIA SYRINGE N PA Document  
abatacept/maltose ORENCIA VIAL N PA Document  
anakinra KINERET SYRINGE N PA Document  
apremilast OTEZLA TAB DS PK N PA Document  
apremilast OTEZLA TABLET N PA Document  
belimumab BENLYSTA AUTO INJCT N PA Document  
belimumab BENLYSTA SYRINGE N PA Document  
brodalumab SILIQ SYRINGE N PA Document  
canakinumab/PF ILARIS VIAL N PA Document  
certolizumab pegol CIMZIA KIT N PA Document  
certolizumab pegol CIMZIA SYRINGEKIT N PA Document  
golimumab SIMPONI PEN INJCTR N PA Document  
golimumab SIMPONI SYRINGE N PA Document  
golimumab SIMPONI ARIA VIAL N PA Document  
guselkumab TREMFYA SYRINGE N PA Document  
infliximab REMICADE VIAL N PA Document  
infliximab-abda RENFLEXIS VIAL N PA Document  
infliximab-dyyb INFLECTRA VIAL N PA Document  
ixekizumab TALTZ AUTOINJECTOR (3 PACK) AUTO INJCT N PA Document Nov 17, 2016
ixekizumab TALTZ AUTOINJECTOR AUTO INJCT N PA Document Nov 17, 2016
ixekizumab TALTZ AUTOINJECTOR (2 PACK) AUTO INJCT N PA Document Nov 17, 2016
ixekizumab TALTZ SYRINGE SYRINGE N PA Document Nov 17, 2016
natalizumab TYSABRI VIAL N PA Document  
rituximab RITUXAN VIAL N PA Document  
sarilumab KEVZARA SYRINGE N PA Document  
secukinumab COSENTYX PEN PEN INJCTR N PA Document Jul 30, 2015
secukinumab COSENTYX PEN (2 PENS) PEN INJCTR N PA Document Jul 30, 2015
secukinumab COSENTYX (2 SYRINGES) SYRINGE N PA Document Jul 30, 2015
secukinumab COSENTYX SYRINGE SYRINGE N PA Document Jul 30, 2015
tocilizumab ACTEMRA SYRINGE N PA Document  
tocilizumab ACTEMRA VIAL N PA Document  
tofacitinib citrate XELJANZ XR TAB ER 24H N PA Document  
tofacitinib citrate XELJANZ TABLET N PA Document  
ustekinumab STELARA SYRINGE N PA Document  
ustekinumab STELARA VIAL N PA Document  
vedolizumab ENTYVIO VIAL N PA Document  
belimumab BENLYSTA VIAL PA Document